henhaobio
Sign in

Journal of NeurochemistryBiochemistryPeer-reviewed journal article

Phosphoinositide- and Collybistin-Dependent Synaptic Clustering of Gephyrin

Nele BurdinaiD, Filip LiebschiD, Arthur MachaiD, Joaquín Lucas Ortuño Gil, Pia Frommelt, Irina RaisiD, Fabian BasleriD, Simon PoepseliD, Günter SchwarziD

PDFDOIPreprint

Abstract

Gephyrin is the main scaffolding protein at inhibitory synapses clustering glycine and GABA type A receptors. At specific GABAergic synapses, the nucleotide exchange factor collybistin recruits gephyrin to the postsynaptic membrane via interaction with phosphoinositides. However, the molecular mechanisms underlying the formation, maintenance and regulation of collybistin-dependent gephyrin clusters remain poorly understood. This study sheds light on the molecular mechanism of gephyrin cluster formation based on gephyrin self-oligomerization induced by collybistin, leading to the formation of a high-molecular weight (>5 MDa) gephyrin-collybistin complex, which is regulated in two ways: First, plasma-membrane phosphoinositides promote complex formation demonstrating their critical role in membrane targeting and stabilization of gephyrin-collybistin clusters at postsynaptic sites. Second, gephyrin phosphorylation at Ser325 abolishes complex formation with collybistin thus impairing collybistin-dependent gephyrin clustering at GABAergic synapses. Collectively, our data demonstrates a molecular mechanism for synaptic clustering of gephyrin which involves collybistin- and phosphoinositide-dependent formation of high-molecular gephyrin oligomers.

Citations
2
FWCI
0.78
Field percentile
top 31%

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISImam '22Ortiz-López '26Chapdelaine '21Kostrz '25Yang '21Merlaud '26
79% semantic matchBiophysics
N. Imam, S. Choudhury, K. Hemmen+2 more·bioRxiv·May 30, 2022